POT1 and central nervous system cancer: While somatic POT1 mutations are most prevalent in angiosarcoma [13], monoallelic POT1 germline mutations are associated with a wide range of cancers, including familial melanoma, chronic lymphocytic leukemia, angiosarcoma and glioma [12,14].